Email Page Print Friendly Page Contact
experience: matters
Private Equity Fund - $25 Million Pharmaceutical Revenue Acquisition
2003

Representation of one of the leading purchasers of private equity in the secondary market in connection with the $25 million acquisition of interests in the revenues generated by pharmaceutical products owned by a university-affiliated research and education institute. (Prior firm experience)